Nvidia to Invest $1 Billion in AI Drug Laboratory With Eli Lilly

Published on January 12, 2026

Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence in the pharmaceutical industry.

Continue reading on website
Other news

Zephyr's Adjusted for Risk: Future-Proofing Your Financial Advisory Business

January 12, 2026
Zephyr's Ryan Nauman and Advisory Services Network's Tom Prescott discuss wealth management M&A trends, selling practices, private equity impact and AI's role in financial advising.

Quantum Computing: Swapping Traffic Lanes for Jetpacks

January 12, 2026
Quantum computing could alter productivity, industrial structure, capital allocation, and even the balance of global power. The transformation won’t happen overnight, but investors who wait for proof may find they have waited too long.